Technology
Latest News
Advertisement
Latest Videos
Advertisement
More News
Advertisement
In part 2 of this video interview, Vincent Keunen, founder & CEO of Andaman7 highlights how technology vendors should be keeping the patient in mind when building solutions.
Wearables have great potential to continue advancing research in Rett syndrome as well as other rare disease areas.
How artificial intelligence can aid in selecting patients, leveraging safety insights, and optimizing combination therapies.
Despite limitations to its widespread use within healthcare, there is great potential for ChatGPT’s application in drug development.
Panna Sharma, CEO of Lantern Pharma, discusses LP-284, using their RADR during testing, ensuring global use, and what the future holds.
A survey conducted at this year’s Pistoia Alliance conference determined that although 70% of life sciences experts acknowledge artificial intelligence’s potential, many still struggle with its initiation and implementation.
Despite the significance offered by AI to pharmaceutical companies, there are several challenges that must be overcome for successful integration of tech-based tools.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
A Shot in the Arm to Traditional Vaccine Trial Strategy
3
Patient Engagement Strategies in Anti-Obesity Medication Clinical Trials: Addressing Drop Out Rate and Improving Retention
4
SCOPE X: What Real-Time Patient Data Is Doing to ClinOps Efficiency
5